Suvretta Capital Management, LLC Aurinia Pharmaceuticals Inc. Transaction History

Suvretta Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $3.09 Million - $4.41 Million	-344,755 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$10.05 - $22.48 $3.46 Million - $7.75 Million	344,755 New	344,755 $4.27 Million
Q4 2020 Feb 16, 2021	SELL	$12.94 - $16.05 $9.52 Million - $11.8 Million	-735,500 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$13.19 - $16.66 $7.65 Million - $9.66 Million	579,800 Added 372.38%	735,500 $10.8 Million
Q2 2020 Aug 14, 2020	BUY	$14.12 - $18.33 $1.06 Million - $1.37 Million	74,900 Added 92.7%	155,700 $2.53 Million

Q1 2020 May 15, 2020	BUY	$11.34 - $21.46 $916,272 - $1.73 Million	80,800 New	80,800 $1.17 Million

205

55.6M

838K

1.18M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $810M
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.